Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study von Martelli, G., Miceli, R., Folli, S., Guzzetti, E., Chifu, C., Maugeri, I., Ferranti, C., Bianchi, G., Capri, G., Carcangiu, M.L., Paolini, B., Agresti, R., Ferraris, C., Piromalli, D., Greco, M.

Volltext

Pitfalls in thyroid tumour pathology von Rosai, J, Kuhn, E, Carcangiu, M L

Volltext

Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours von Perotti, A., Sessa, C., Mancuso, A., Noberasco, C., Cresta, S., Locatelli, A., Carcangiu, M. L., Passera, K., Braghetti, A., Scaramuzza, D., Zanaboni, F., Fasolo, A., Capri, G., Miani, M., Peters, W. P., Gianni, L.

Volltext

Management of breast cancer after Hodgkin’s lymphoma and paediatric cancer von Terenziani, M, Massimino, M, Magazzù, D, Gandola, L, Capri, G, Carcangiu, M.L, Catania, S, Di Russo, A, Gennaro, M, Meazza, C, Podda, M, Schiavello, E, Valagussa, P

Volltext

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes von TALLINI, G, SANTORO, M, HELIE, M, CARLOMAGNO, F, SALVATORE, G, CHIAPPETTA, G, CARCANGIU, M. L, FUSCO, A

Volltext

Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma von GARCIA-ROSTAN, G, TALLINI, G, HERRERO, A, D'AQUILA, T. G, CARCANGIU, M. L, RIMM, D. L

Volltext

Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction von Xu, Tian, St John, Maie A R, Tao, Wufan, Fei, Xiaolan, Fukumoto, Royd, Carcangiu, Maria Luisa, Brownstein, David G, Parlow, Albert F, McGrath, James

Volltext

How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy? von Martinelli, F, Bogani, G, Ditto, A, Carcangiu, M, Papadia, A, Lecce, F, Chiappa, V, Lorusso, D, Raspagliesi, F

Volltext

Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38–45] von Ripamonti, C.B., Manoukian, S., Peissel, B., Azzollini, J., Carcangiu, M.L., Radice, P.

Volltext

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score von Ménard, S., Balsari, A., Tagliabue, E., Camerini, T., Casalini, P., Bufalino, R., Castiglioni, F., Carcangiu, M.L., Gloghini, A., Scalone, S., Querzoli, P., Lunardi, M., Molino, A., Mandarà, M., Mottolese, M., Marandino, F., Venturini, M., Bighin, C., Cancello, G., Montagna, E., Perrone, F., De Matteis, A., Sapino, A., Donadio, M., Battelli, N., Santinelli, A., Pavesi, L., Lanza, A., Zito, F.A., Labriola, A., Aiello, R.A., Caruso, M., Zanconati, F., Mustacchi, G., Barbareschi, M., Frisinghelli, M., Russo, R., Carrillo, G.

Volltext

Alterations in Notch Signaling in Neoplastic Lesions of the Human Cervix von Zagouras, P, Stifani, S, Blaumueller, C M, Carcangiu, M L, Artavanis-Tsakonas, S

Volltext

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients von MAGRIPLES, U, NAFTOLIN, F, SCHWARTZ, P. E, CARCANGIU, M. L

Volltext

Class II versus Class III radical hysterectomy in early cervical cancer: An observational study in a tertiary center von Ditto, A, Martinelli, F, Ramondino, S, Vullo, S.L, Carcangiu, M, Haeusler, E, Mariani, L, Lorusso, D, Raspagliesi, F

Volltext

Human Ligands of the Notch Receptor von Gray, Grace E., Mann, Robert S., Mitsiadis, Efthimios, Henrique, Domingos, Carcangiu, Maria-Louisa, Banks, Amy, Leiman, John, Ward, David, Ish-Horowitz, David, Artavanis-Tsakonas, Spyros

Volltext

Genetic analysis of benign, low-grade, and high-grade ovarian tumors von IWABUCHI, H, SAKAMOTO, M, SAKUNAGA, H, YEN-YING MA, CARCANGIU, M. L, PINKEL, D, YANG-FENG, T. L, GRAY, J. W

Volltext

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prog... von Garcia-Rostan, G, Camp, R L, Herrero, A, Carcangiu, M L, Rimm, D L, Tallini, G

Volltext

Stage IA uterine serous carcinoma : A study of 13 cases von CARCANGIU, M. L, TAN, L. K, CHAMBERS, J. T

Volltext

Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? von Schwartz, Lisa Barrie, Zawin, Marlene, Carcangiu, Maria Louisa, Lange, Robert, McCarthy, Shirley

Volltext

Plasminogen activator inhibitor‐1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients von Chambers, Setsuko K., Ivins, Christina M., Carcangiu, Maria L.

Volltext

Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective ef... von Chambers, S K, Kacinski, B M, Ivins, C M, Carcangiu, M L

Volltext